CMHC West

May 4-5, 2018

Wynn Las Vegas

Advancing Cardiometabolic Health from East to West


Satellite Symposium Accreditation


CME Breakfast Symposium · Saturday, May 5, 2018 · 7:40 – 8:55am

Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life


Target Audience

CMHC West is designed for US-based healthcare professionals, including primary care clinicians (PCPs), nurse practitioners (NPs), physician assistants (PAs), endocrinologists, diabetologists, pharmacists, cardiologists, lipidologists, and other allied health professionals.

Program Overview

Iron deficiency (ID) affects up to one-third of the world's population and is particularly common in elderly individuals and those with certain chronic diseases such as chronic kidney disease, and congestive heart failure. Many of those affected are unaware of ID and cannot recognize its symptoms. For patients with heart failure (HF), ID is an independent predictor of outcomes and a major contributor to exercise intolerance. At least half of all patients with HF have comorbid ID; yet, the condition is under-recognized and untreated in most patients.

In this symposium, experts will provide participants with data from recent and ongoing trials of iron repletion in patients with HF to highlight the importance of diagnosis and proper management of this common comorbidity. Recent updates to established HF treatment guidelines that emphasize ID recognition and treatment will also be addressed. Additionally, the program will educate clinicians on the differences in oral versus intravenous iron formulations

Educational Objectives

After completing this activity, the participant should be better able to:

  • Describe the prevalence of iron deficiency (ID) in heart failure (HF) and its impact on patient outcomes and quality of life
  • Identify the symptoms of ID using appropriate markers in HF patients in order to diagnose ID
  • Discuss the updated ACC/AHA/HFSA and ESC recommended guidelines for the management of iron deficiency in patients with HF
  • Review evidence from major clinical trials assessing the efficacy and safety of iron supplementation in HF patients to improve patient outcomes and reduce HF hospitalizations

Faculty

Clyde W. Yancy, MD, MSc, MACP
Clyde W. Yancy, MD, MSc, MACP (Chair)
  • Magerstadt Professor of Medicine
  • Professor of Medical Social Sciences
  • Chief, Div. of Cardiology, Northwestern Univ.
  • Feinberg School of Medicine
  • Assoc. Director, Bluhm Cardiovascular Institute
  • Northwestern Memorial Hospital
  • Chicago, IL

Biykem Bozkurt, MD, PhD, FACC, FAHA
Biykem Bozkurt, MD, PhD, FACC, FAHA
  • The Mary and Gordon Cain and
  • W.A. “Tex” and Deborah Moncrief, Jr., Chair
  • Professor of Medicine
  • Medical Care Line Executive, DeBakey VA Medical Center
  • Director, Winters Center for Heart Failure Research
  • Associate Director, Cardiovascular Research Institute
  • Baylor College of Medicine
  • Houston, TX

Gurusher Panjrath, MD
Gurusher Panjrath, MD
  • Director, Heart Failure and Mechanical Circulatory Support Program
  • Assistant Professor of Medicine
  • George Washington University School of Medicine
  • Washington DC

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and CMHC. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Nursing Practitioners Continuing Education

This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and CMHC. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024. This activity is approved for 1.25 contact hour(s) which includes 0.6 pharmacotherapy hours. To claim AANP credit, please contact Global at 303-395-1782 or cme@globaleducationgroup.com. Activity ID #2643L. This activity was planned in accordance with AANP CE Standards and Policies.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity for 1.25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

Global Education Group designates this continuing education activity for 1.25 contact hour(s) (0.125 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Numbers (UAN): 0530-9999-18-108-L01-P

Dietician Accreditation Statement

Global Education Group is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.25 Continuing Professional Education units (CPEUs) for completion of this activities / materials. CPE Provider #GE012

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must complete the CMHC Program Evaluation provided at the time of this activity. An evaluation will be available to complete after the symposium via iPads that will be provided to all attendees. Upon completion of the evaluation, participants will be emailed their CME/CE Certificates within 5-7 business days.

Pharmacists Only: In order to receive credit, the ACPE requires that you provide your NABP ePID (6 digits) along with month and date of birth (MMDD) in the online evaluation. After completion of the evaluation via steps outlined above, record of your participation will be uploaded to the CPE Monitor under your NABP e-profile within 60 days. You may print an individual statement of credit for this activity from your NABP e-profile. CMHC strongly encourages you to check your e-profile to ensure your credit is appropriately claimed before July 3, 2018.

Fee Information & Refund/Cancellation Policy

There is registration fee for this educational activity, registration information can be found here.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner or Manager

Reported Financial Relationship

Ashley Marostica, RN, MSN

Nothing to disclose

Lindsay Borvansky

Nothing to disclose

Andrea Funk

Nothing to disclose

Amanda Turner

Nothing to disclose

Kristin Delisi, NP

Nothing to disclose

Erin Franceschini, MS

Nothing to disclose

Amanda Jamrogiewicz

Nothing to disclose

Karin McAdams

Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and CMHC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Educational Grant Support

This satellite symposium is supported by an educational grant from American Regent.

Joint Providership Statement

This activity is jointly provided by Global Education Group and Tarsus Cardio Inc. dba Cardiometabolic Health Congress.


To view the full CMHC West satellite symposia schedule, please visit this page.

To view the full CMHC West agenda, please visit this page